Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2025)

BioNexus Gene Lab's Cash from Financing Activities history spans 8 years, with the latest figure at $266544.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $266544.0 for Q4 2025, up 287.2% from a year ago — trailing twelve months through Dec 2025 was $298841.0 (up 7418.01% YoY), and the annual figure for FY2025 was $298841.0, up 7418.01%.
  • Cash from Financing Activities for Q4 2025 was $266544.0 at BioNexus Gene Lab, up from $34187.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $5.7 million in Q3 2023 to a low of -$142387.0 in Q4 2024.
  • The 5-year median for Cash from Financing Activities is -$1736.0 (2022), against an average of $350405.3.
  • The sharpest move saw Cash from Financing Activities crashed 378.18% in 2021, then surged 331172.47% in 2023.
  • Year by year, Cash from Financing Activities stood at -$4959.0 in 2021, then skyrocketed by 54.16% to -$2273.0 in 2022, then surged by 23493.44% to $531733.0 in 2023, then tumbled by 126.78% to -$142387.0 in 2024, then skyrocketed by 287.2% to $266544.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $266544.0, $34187.0, and -$1030.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.